Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHE-OX-ANT
NCT07369232Completed
- Sponsor
- Erasmus Hospital
- Start
- Sep 2025
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial in hyperoxemia comparing Placebo Pre-Treatment + Oxygen with Vitamin C Pre-Treatment + Oxygen (2 arms). Primary endpoints: Change in circulating microparticle concentration (total MPs - EV) and Change in oxidative stress and antioxidant status. Started Sep 2025; status: completed.
02
Drugs
ascorbic acid
03
Conditions
hyperoxemia
Beyond the preview
Go deeper on NCT07369232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07369232.